tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Liisa Bayko, 166 are a BUY (85.57%), 25 are a HOLD (12.89%), 3 are a SELL (1.55%).
Analyst Liisa Bayko, currently employed at EVERCORE, carries an average stock price target met ratio of 46.31% that have a potential upside of 46.53% achieved within 267 days.
Liisa Bayko’s has documented 377 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on ALT, Altimmune at 23-Sep-2026.
Analyst best performing recommendations are on TBI (TRUEBLUE).
The best stock recommendation documented was for ENTA (ENANTA PHARMACEUTICALS) at 9/15/2025. The price target of $12 was fulfilled within 14 days with a profit of $4.54 (60.86%) receiving and performance score of 43.47.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 15-Sep-2020
$5
$0.42 (9.17%)
$5
10 months 18 days ago
(14-Nov-2025)
4/14 (28.57%)
$0.48 (10.62%)
136
Buy Since 05-Nov-2021
$5
$0.42 (9.17%)
$5
1 years 6 months 1 days ago
(31-Mar-2025)
2/10 (20%)
$1.51 (43.27%)
256
Buy Since 17-Dec-2020
$5
$0.42 (9.17%)
$5
1 years 8 months 11 days ago
(21-Jan-2025)
0/18 (0%)
$1.79 (55.76%)
Hold Since 29-Dec-2021
$5
$0.55 (12.36%)
$4
4 years 8 months 1 days ago
(02-Feb-2022)
2/2 (100%)
$2.11 (73.01%)
1298
Buy Since 05-Mar-2020
$7
$2.55 (57.30%)
$7
5 years 3 months 5 days ago
(28-Jun-2021)
0/6 (0%)
$3.63 (107.72%)
Which stock is Liisa Bayko most bullish on?
Which stock is Liisa Bayko most reserved on?
What Year was the first public recommendation made by Liisa Bayko?
